Focused ultrasound may enhance chemotherapy, survival outcomes for pancreatic cancer

Medical Xpress

A phase 2 clinical trial published in the European Journal of Cancer suggests that a novel form of focused ultrasound combined with standard FOLFIRINOX chemotherapy may improve tumor response and survival outcomes in patients with either borderline resectable pancreatic cancer or locally advanced pancreatic cancer, with a safety profile comparable to chemotherapy alone. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

Focused ultrasound may enhance chemotherapy, survival outcomes for pancreatic cancer

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Colorado basins supplying 70% of Lake Powell's water face major midcentury shortages

Beyond antibiotics—a paradigm shift toward bacteria-control-centric therapies

Overlooked brain protein tied to epilepsy yields first inhibitors in early experiments

Medical Xpress의 다른 기사

New PPAR therapies could slow fibrosis in primary biliary cholangitis

New strategy could prevent T cell exhaustion and boost immunotherapy

Burden of myocardial dysfunction elevated for individuals with psoriasis